Ultrasound induced cancer immunotherapy

Advanced Drug Delivery Reviews

Volumn 72, Issue , 2014, Pages 144-153

  Unga, Johan ^a,b   Hashida, Mitsuru ^a,c  

^a KYOTO UNIVERSITY   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Bubble liposomes; HIFU; Immunity; Microbubbles; Nanobubbles; Tumor ablation; Tumor vaccine

Indexed keywords

ANTIGENS; CELLS; CYTOLOGY; DISEASES; GENES; LIPOSOMES; TUMORS; ULTRASONICS;

BUBBLE LIPOSOMES; HIFU; IMMUNITY; MICROBUBBLES; NANOBUBBLES; TUMOR ABLATION; TUMOR VACCINES;

IMMUNE SYSTEM;

ANIMAL; HUMAN; IMMUNOTHERAPY; NEOPLASMS; ULTRASOUND;

ANIMALS; HUMANS; IMMUNOTHERAPY; NEOPLASMS; ULTRASONICS;

EID: 84901635155     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2014.03.004     Document Type: Review

References (105)

1. Lindau D., Gielen P., Kroesen M., Wesseling P., Adema G.J. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology 2013, 138:105-115.
2. Topalian S.L., Weiner G.J., Pardoll D.M. Cancer immunotherapy comes of age. J. Clin. Oncol. 2011, 29:4828-4836.
3. Kirkwood J.M., Butterfield L.H., Tarhini A.A., Zarour H., Kalinski P., Ferrone S. Immunotherapy of cancer in 2012. CA Cancer J. Clin. 2012, 62:309-335.
4. Mellman I., Coukos G., Dranoff G. Cancer immunotherapy comes of age. Nature 2011, 480:480-489.
5. Pathak S.K., Skold A.E., Mohanram V., Persson C., Johansson U., Spetz A.L. Activated apoptotic cells induce dendritic cell maturation via engagement of Toll-like receptor 4 (TLR4), dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN), and beta2 integrins. J. Biol. Chem. 2012, 287:13731-13742.
6. Melief C.J.M. Cancer immunotherapy by dendritic cells. Immunity 2008, 29:372-383.
7. Weiner L.M., Murray J.C., Shuptrine C.W. Antibody-based immunotherapy of cancer. Cell 2012, 148:1081-1084.
8. Scott A.M., Wolchok J.D., Old L.J. Antibody therapy of cancer. Nat. Rev. Cancer 2012, 12:278-287.
9. Chiang C.L.L., Benencia F., Coukos G. Whole tumor antigen vaccines. Semin. Immunol. 2010, 22:132-143.
10. Rosenberg S.A., Restifo N.P., Yang J.C., Morgan R.A., Dudley M.E. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat. Rev. Cancer 2008, 8:299-308.
11. Palucka K., Ueno H., Banchereau J. Recent developments in cancer vaccines. J. Immunol. 2011, 186:1325-1331.
12. Rice J., Ottensmeier C.H., Stevenson F.K. DNA vaccines: precision tools for activating effective immunity against cancer. Nat. Rev. Cancer 2008, 8:108-120.
13. Sandler A., Gray R., Perry M.C., Brahmer J., Schiller J.H., Dowlati A., Lilenbaum R., Johnson D.H. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N. Engl. J. Med. 2006, 355:2542-2550.
14. Marcus R., Imrie K., Belch A., Cunningham D., Flores E., Catalano J., Solal-Celigny P., Offner F., Walewski J., Raposo J., Jack A., Smith P. CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. Blood 2005, 105:1417-1423.
15. Olson B.M., McNeel D.G. Sipuleucel-T: immunotherapy for advanced prostate cancer. Open Access J. Urol. 2011, 3:49-60.
16. O'Brien W.D. Ultrasound-biophysics mechanisms. Prog. Biophys. Mol. Biol. 2007, 93:212-255.
17. Shankar H., Pagel P.S. Potential adverse ultrasound-related biological effects a critical review. Anesthesiology 2011, 115:1109-1124.
18. Barnett S.B., Rott H.D., terHaar G.R., Ziskin M.C., Maeda K. The sensitivity of biological tissue to ultrasound. Ultrasound Med. Biol. 1997, 23:805-812.
19. Rosenthal I., Sostaric J.Z., Riesz P. Sonodynamic therapy - a review of the synergistic effects of drugs and ultrasound. Ultrason. Sonochem. 2004, 11:349-363.
20. Riesz P., Kondo T. Free-radical formation induced by ultrasound and its biological implications. Free Radic. Biol. Med. 1992, 13:247-270.
21. Raja J., Ramachandran N., Munneke G., Patel U. Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer. Clin. Radiol. 2006, 61:142-153.
22. Lencioni R., Piscaglia F., Bolondi L. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. J. Hepatol. 2008, 48:848-857.
23. Paliwal S., Mitragotri S. Therapeutic opportunities in biological responses of ultrasound. Ultrasonics 2008, 48:271-278.
24. Webster D.F., Pond J.B., Dyson M., Harvey W. The role of cavitation in the in vitro stimulation of protein synthesis in human fibroblasts by ultrasound. Ultrasound Med. Biol. 1978, 4:343-351.
25. Zhou S.X., Bachem M.G., Seufferlein T., Li Y.P., Gross H.J., Schmelz A. Low intensity pulsed ultrasound accelerates macrophage phagocytosis by a pathway that requires actin polymerization, Rho, and Src/MAPKs activity. Cell. Signal. 2008, 20:695-704.
26. Grull H., Langereis S. Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound. J. Control. Release 2012, 161:317-327.
27. Geers B., Lentacker I., Cool S., Demeester J., De Smedt S.C., Sanders N.N. Ultrasound responsive doxorubicin-loaded microbubbles; towards an easy applicable drug delivery platform. J. Control. Release 2010, 148:E59-E60.
28. Shiraishi K., Endoh R., Furuhata H., Nishihara M., Suzuki R., Maruyama K., Oda Y., Jo J.-I., Tabata Y., Yamamoto J., Yokoyama M. A facile preparation method of a PFC-containing nano-sized emulsion for theranostics of solid tumors. Int. J. Pharm. 2011, 421:379-387.
29. Polat B.E., Hart D., Langer R., Blankschtein D. Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends. J. Control. Release 2011, 152:330-348.
30. Shohet R.V., Chen S.Y., Zhou Y.T., Wang Z.W., Meidell R.S., Unger T.H., Grayburn P.A. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000, 101:2554-2556.
31. Hynynen K. Ultrasound for drug and gene delivery to the brain. Adv. Drug Deliv. Rev. 2008, 60:1209-1217.
32. Pislaru S.V., Pislaru C., Kinnick R.R., Singh R., Gulati R., Greenleaf J.F., Simari R.D. Optimization of ultrasound-mediated gene transfer: comparison of contrast agents and ultrasound modalities. Eur. Heart J. 2003, 24:1690-1698.
33. Mehier-Humbert S., Bettinger T., Yan F., Guy R.H. Plasma membrane poration induced by ultrasound exposure: implication for drug delivery. J. Control. Release 2005, 104:213-222.
34. Mo S., Coussios C.C., Seymour L., Carlisle R. Ultrasound-enhanced drug delivery for cancer. Expert Opin. Drug Deliv. 2012, 9:1525-1538.
35. Dromi S.A., Walsh M.P., Herby S., Traughber B., Xie J.W., Sharma K.V., Sekhar K.P., Luk A., Liewehr D.J., Dreher M.R., Fry T.J., Wood B.J. Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity. Radiology 2009, 251:58-66.
36. Martin R.C.G., Scoggins C.R., McMasters K.M. Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann. Surg. Oncol. 2010, 17:171-178.
37. Haen S.P., Pereira P.L., Salih H.R., Rammensee H.G., Gouttefangeas C. More than just tumor destruction: immunomodulation by thermal ablation of cancer. Clin. Dev. Immunol. 2011, 160250. (Epub 2011 Dec 29) (http://www.ncbi.nlm.nih.gov/pubmed/22242035). 10.1155/2011/160250.
38. den Brok M.H., Sutmuller R.P., Nierkens S., Bennink E.J., Frielink C., Toonen L.W., Boerman O.C., Figdor C.G., Ruers T.J., Adema G.J. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. Br. J. Cancer 2006, 95:896-905.
39. Matin S.F., Sharma P., Gill I.S., Tannenbaum C., Hobart M.G., Novick A.C., Finke J.H. Immunological response to renal cryoablation in an in vivo orthotopic renal cell carcinoma murine model. J. Urol. 2010, 183:333-338.
40. Sidana A. Cancer immunotherapy using tumor cryoablation. Immunotherapy 2014, 6:85-93.
41. Ter Haar G., Coussios C. High intensity focused ultrasound: physical principles and devices. Int. J. Hyperthermia 2007, 23:89-104.
42. Hu Z., Yang X.Y., Liu Y., Sankin G.N., Pua E.C., Morse M.A., Lyerly H.K., Clay T.M., Zhong P. Investigation of HIFU-induced anti-tumor immunity in a murine tumor model. J. Transl. Med. 2007, 5.
43. Filonenko E.A., Khokhlova V.A. Effect of acoustic nonlinearity on heating of biological tissue by high-intensity focused ultrasound. Acoust. Phys. 2001, 47:468-475.
44. Canney M.S., Khokhlova V.A., Bessonova O.V., Bailey M.R., Crum L.A. Shock-induced heating and millisecond boiling in gels and tissue due to high intensity focused ultrasound. Ultrasound Med. Biol. 2010, 36:250-267.
45. Wang Y.-N., Khokhlova T., Bailey M., Hwang J.H., Khokhlova V. Histological and biochemical analysis of mechanical and thermal bioeffects in boiling histotripsy lesions induced by high intensity focused ultrasound. Ultrasound Med. Biol. 2013, 39:424-438.
46. Al-Bataineh O., Jenne J., Huber P. Clinical and future applications of high intensity focused ultrasound in cancer. Cancer Treat. Rev. 2012, 38:346-353.
47. Yang R., Reilly C.R., Rescorla F.J., Sanghvi N.T., Fry F.J., Franklin T.D., Grosfeld J.L. Effects of high-intensity focused ultrasound in the treatment of experimental neuroblastoma. J. Pediatr. Surg. 1992, 27:246-251.
48. Huang X.Y., Yuan F., Liang M.H., Lo H.W., Shinohara M.L., Robertson C., Zhong P. M-HIFU inhibits tumor growth, suppresses STAT3 activity and enhances tumor specific immunity in a transplant tumor model of prostate cancer. PLoS One 2012, 7.
49. Zhou Q., Zhu X.Q., Zhang J., Xu Z.L., Lu P., Wu F. Changes in circulating immunosuppressive cytokine levels of cancer patients after high intensity focused ultrasound treatment. Ultrasound Med. Biol. 2008, 34:81-87.
50. Rosberger D.F., Coleman D.J., Silverman R., Woods S., Rondeau M., Cunningham-Rundles S. Immunomodulation in choroidal melanoma: reversal of inverted CD4/CD8 ratios following treatment with ultrasonic hyperthermia. Biotechnol. Ther. 1994, 5:59-68.
51. Wu F., Wang Z.B., Lu P., Xu Z.L., Chen W.Z., Zhu H., Jin C.B. Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med. Biol. 2004, 30:1217-1222.
52. Hu Z.L., Yang X.Y., Liu Y.B., Morse M.A., Lyerly H.K., Clay T.M., Zhong P. Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs. Biochem. Biophys. Res. Commun. 2005, 335:124-131.
53. Zhang Y., Deng J.A., Feng J., Wu F. Enhancement of antitumor vaccine in ablated hepatocellular carcinoma by high-intensity focused ultrasound. World J. Gastroenterol. 2010, 16:3584-3591.
54. Xia J.Z., Xie F.L., Ran L.F., Xie X.P., Fan Y.M., Wu F. High-intensity focused ultrasound tumor ablation activates autologous tumor-specific cytotoxic T lymphocytes. Ultrasound Med. Biol. 2012, 38:1363-1371.
55. Deng J., Zhang Y., Feng J., Wu F. Dendritic cells loaded with ultrasound-ablated tumour induce in vivo specific antitumour immune responses. Ultrasound Med. Biol. 2010, 36:441-448.
56. Kramer G., Steiner G.E., Grobl M., Hrachowitz K., Reithmayr F., Paucz L., Newman M., Madersbacher S., Gruber D., Susani M., Marberger M. Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T-cells. Prostate 2004, 58:109-120.
57. Wu F., Wang Z.B., Cao Y.D., Zhou Q., Zhang Y., Xu Z.L., Zhu X.Q. Expression of tumor antigens and heat-shock protein 70 in breast cancer cells after high-intensity focused ultrasound ablation. Ann. Surg. Oncol. 2007, 14:1237-1242.
58. Liu H.L., Hsieh H.Y., Lu L.A., Kang C.W., Wu M.F., Lin C.Y. Low-pressure pulsed focused ultrasound with microbubbles promotes an anticancer immunological response. J. Transl. Med. 2012, 10:1479-5876.
59. Liu F., Hu Z.L., Qiu L., Hui C., Li C., Zhong P., Zhang J.P. Boosting high-intensity focused ultrasound-induced anti-tumor immunity using a sparse-scan strategy that can more effectively promote dendritic cell maturation. J. Transl. Med. 2010, 8.
60. Lu P., Zhu X.Q., Xu Z.L., Zhou Q., Zhang J., Wu F. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer. Surgery 2009, 145:286-293.
61. Jung S.E., Cho S.H., Jang J.H., Han J.Y. High-intensity focused ultrasound ablation in hepatic and pancreatic cancer: complications. Abdom. Imaging 2011, 36:185-195.
62. Xing Y.F., Lu X.C., Pua E.C., Zhong P. The effect of high intensity focused ultrasound treatment on metastases in a murine melanoma model. Biochem. Biophys. Res. Commun. 2008, 375:645-650.
63. Tachibana K., Uchida T., Ogawa K., Yamashita N., Tamura K. Induction of cell-membrane porosity by ultrasound. Lancet 1999, 353:1409.
64. Nagle J.F., Tristram-Nagle S. Structure of lipid bilayers. Biochim. Biophys. Acta - Rev. Biomembr. 2000, 1469:159-195.
65. Hancock H.A., Smith L.H., Cuesta J., Durrani A.K., Angstadt M., Palmeri M.L., Kimmel E., Frenkel V. Investigations into pulsed high-intensity focused ultrasound-enhanced delivery: preliminary evidence for a novel mechanism. Ultrasound Med. Biol. 2009, 35:1722-1736.
66. Casey G., Cashman J.P., Morrissey D., Whelan M.C., Larkin J.O., Soden D.M., Tangney M., O'Sullivan G.C. Sonoporation mediated immunogene therapy of solid tumors. Ultrasound Med. Biol. 2010, 36:430-440.
67. Zarnitsyn V.G., Prausnitz M.R. Physical parameters influencing optimization of ultrasound-mediated DNA transfection. Ultrasound Med. Biol. 2004, 30:527-538.
68. Huber P.E., Pfisterer P. In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound. Gene Ther. 2000, 7:1516-1525.
69. Hayashi S., Mizuno M., Yoshida J., Nakao A. Effect of sonoporation on cationic liposome-mediated IFNβ gene therapy for metastatic hepatic tumors of murine colon cancer. Cancer Gene Ther. 2009, 16:638-643.
70. Danno D., Kanno M., Fujimoto S., Feril L.B., Kondo T., Nakamura S. Effects of ultrasound on apoptosis induced by anti-CD20 antibody in CD20-positive B lymphoma cells. Ultrason. Sonochem. 2008, 15:463-471.
71. Masui T., Ota I., Kanno M., Yane K., Hosoi H. Low-intensity ultrasound enhances the anticancer activity of cetuximab in human head and neck cancer cells. Exp. Ther. Med. 2013, 5:11-16.
72. Khaibullina A., Jang B.S., Sun H., Lee N., Yu S., Frenkel V., Carrasquillo J.A., Pastan I., Li K.C.P., Paik C.H. Pulsed high-intensity focused ultrasound enhances uptake of radiolabeled monoclonal antibody to human epidermoid tumor in nude mice. J. Nucl. Med. 2008, 49:295-302.
73. Wang S., Shin I.S., Hancock H., Jang B.S., Kim H.S., Lee S.M., Zderic V., Frenkel V., Pastan I., Paik C.H., Dreher M.R. Pulsed high intensity focused ultrasound increases penetration and therapeutic efficacy of monoclonal antibodies in murine xenograft tumors. J. Control. Release 2012, 162:218-224.
74. Bouakaz A., Versluis M., de Jong N. High-speed optical observations of contrast agent destruction. Ultrasound Med. Biol. 2005, 31:391-399.
75. Villarraga H.R., Foley D.A., Aeschbacher B.C., Klarich K.W., Mulvagh S.L. Destruction of contrast microbubbles during ultrasound imaging at conventional power output. J. Am. Soc. Echocardiogr. 1997, 10:783-791.
76. Wei K., Skyba D.M., Firschke C., Jayaweera A.R., Lindner J.R., Kaul S. Interactions between microbubbles and ultrasound: In vitro and in vivo observations. J. Am. Coll. Cardiol. 1997, 29:1081-1088.
77. Duvshani-Eshet M., Adam D., Machluf M. The effects of albumin-coated microbubbles in DNA delivery mediated by therapeutic ultrasound. J. Control. Release 2006, 112:156-166.
78. Ibsen S., Benchimol M., Esener S. Fluorescent microscope system to monitor real-time interactions between focused ultrasound, echogenic drug delivery vehicles, and live cell membranes. Ultrasonics 2013, 53:178-184.
79. van Wamel A., Kooiman K., Harteveld M., Emmer M., ten Cate F.J., Versluis M., de Jong N. Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J. Control. Release 2006, 112:149-155.
80. Suzuki R., Oda Y., Utoguchi N., Maruyama K. Progress in the development of ultrasound-mediated gene delivery systems utilizing nano- and microbubbles. J. Control. Release 2011, 149:36-41.
81. Zhou Y., Yang K., Cui J., Ye J.Y., Deng C.X. Controlled permeation of cell membrane by single bubble acoustic cavitation. J. Control. Release 2012, 157:103-111.
82. Tinkov S., Bekeredjian R., Winter G., Coester C. Microbubbles as ultrasound triggered drug carriers. J. Pharm. Sci. 2009, 98:1935-1961.
83. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 2000, 65:271-284.
84. Fang J., Nakamura H., Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliv. Rev. 2011, 63:136-151.
85. Greenleaf W.J., Bolander M.E., Sarkar G., Goldring M.B., Greenleaf J.F. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound Med. Biol. 1998, 24:587-595.
86. Sakakima Y., Hayashi S., Yagi Y., Hayakawa A., Tachibana K., Nakao A. Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents. Cancer Gene Ther. 2005, 12:884-889.
87. Zolochevska O., Xia X.Q., Williams B.J., Ramsay A., Li S.L., Figueiredo M.L. Sonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo. Hum. Gene Ther. 2011, 22:1537-1550.
88. Taniyama Y., Tachibana K., Hiraoka K., Aoki M., Yamamoto S., Matsumoto K., Nakamura T., Ogihara T., Kaneda Y., Morishita R. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther. 2002, 9:372-380.
89. Alkins R.D., Burgess A., Ganguly M., Francia G., Kerbel R.S., Wels W.S., Hynynen K. Focused ultrasound delivers targeted immune cells to metastatic brain tumors. Cancer Res. 2013, 9:9.
90. Bioley G., Lassus A., Bussat P., Terrettaz J., Tranquart F., Corthesy B. Gas-filled microbubble-mediated delivery of antigen and the induction of immune responses. Biomaterials 2012, 33:5935-5946.
91. De Temmerman M.-L., Dewitte H., Vandenbroucke R.E., Lucas B., Libert C., Demeester J., De S.S.C., Lentacker I., Rejman J. mRNA-Lipoplex loaded microbubble contrast agents for ultrasound-assisted transfection of dendritic cells. Biomaterials 2011, 32:9128-9135.
92. Lentacker I., Wang N., Vandenbroucke R.E., Demeester J., De Smedt S.C., Sander N.N. Ultrasound exposure of lipoplex loaded microbubbles facilitates direct cytoplasmic entry of the lipoplexes. Mol. Pharm. 2009, 6:457-467.
93. Lemmon J.C.M., McFarland R.J., Rybicka J.M., Balce D.R., McKeown K.R., Krohn R.M., Matsunaga T.O., Yates R.M. In vitro and in vivo transfection of primary phagocytes via microbubble-mediated intraphagosomal sonoporation. J. Immunol. Methods 2011, 371:152-158.
94. Liao Z.K., Tsai K.C., Wang H.T., Tseng S.H., Deng W.P., Chen W.S., Hwang L.H. Sonoporation-mediated anti-angiogenic gene transfer into muscle effectively regresses distant orthotopic tumors. Cancer Gene Ther. 2012, 19:171-180.
95. Oda Y., Suzuki R., Otake S., Nishiie N., Hirata K., Koshima R., Nomura T., Utoguchi N., Kudo N., Tachibana K., Maruyama K. Prophylactic immunization with bubble liposomes and ultrasound-treated dendritic cells provided a four-fold decrease in the frequency of melanoma lung metastasis. J. Control. Release 2012, 160:362-366.
96. Suzuki R., Namai E., Oda Y., Nishiie N., Otake S., Koshima R., Hirata K., Taira Y., Utoguchi N., Negishi Y., Nakagawa S., Maruyama K. Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. J. Control. Release 2010, 142:245-250.
97. Un K., Kawakami S., Suzuki R., Maruyama K., Yamashita F., Hashida M. Enhanced transfection efficiency into macrophages and dendritic cells by a combination method using mannosylated lipoplexes and bubble liposomes with ultrasound exposure. Hum. Gene Ther. 2010, 21:65-74.
98. Un K., Kawakami S., Suzuki R., Maruyama K., Yamashita F., Hashida M. Suppression of melanoma growth and metastasis by DNA vaccination using an ultrasound-responsive and mannose-modified gene carrier. Mol. Pharm. 2011, 8:543-554.
99. Suzuki R., Oda Y., Utoguchi N., Namai E., Taira Y., Okada N., Kadowaki N., Kodama T., Tachibana K., Maruyama K. A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy. J. Control. Release 2009, 133:198-205.
100. Suzuki R., Takizawa T., Negishi Y., Hagisawa K., Tanaka K., Sawamura K., Utoguchi N., Nishioka T., Maruyama K. Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound. J. Control. Release 2007, 117:130-136.
101. Un K., Kawakami S., Suzuki R., Maruyama K., Yamashita F., Hashida M. Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy. Biomaterials 2010, 31:7813-7826.
102. Un K., Kawakami S., Yoshida M., Higuchi Y., Suzuki R., Maruyama K., Yamashita F., Hashida M. The elucidation of gene transferring mechanism by ultrasound-responsive unmodified and mannose-modified lipoplexes. Biomaterials 2011, 32:4659-4669.
103. Un K., Kawakami S., Higuchi Y., Suzuki R., Maruyama K., Yamashita F., Hashida M. Involvement of activated transcriptional process in efficient gene transfection using unmodified and mannose-modified bubble lipoplexes with ultrasound exposure. J. Control. Release 2011, 156:355-363.
104. Fabiilli M.L., Lee J.A., Kripfgans O.D., Carson P.L., Fowlkes J.B. Delivery of water-soluble drugs using acoustically triggered perfluorocarbon double emulsions. Pharm. Res. 2010, 27:2753-2765.
105. Singh R., Husseini G.A., Pitt W.G. Phase transitions of nanoemulsions using ultrasound: experimental observations. Ultrason. Sonochem. 2012, 19:1120-1125.